Identification of stage I b specific related genes in lung squmous cell cancer by oligonucleotide array

National Medical Journal of China

Volumn 85, Issue 37, 2005, Pages 2623-2628

  Li, Ang ^a   Yan, Wen Sheng ^b   Liang, Qi Wan ^b   Liu, Ji Hong ^b   Wang, Jia Xiang ^b   Zhao, Song ^b   Fang, Yan ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b NONE

Author keywords

Gene expression profile; Lung neoplasms; Oligonucleotide array

Indexed keywords

OLIGONUCLEOTIDE; RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENOME; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; VALIDATION PROCESS; GENETICS; LUNG TUMOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 27644521365     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Liao ML. Multidisciplinary synthetic therapy based on surgery of lung cancer. Natl Med J China, 2003, 83: 181-182.
2. Li A, Zhang XS, Jiang JH, et al. Transcriptional carcinoma and its oncogenic potential. Cell Cycle, 2004, 4: 304-309.
3. The Tumor Analysis Best Practices Working Group. Expression profiling-best practices for data generation and interpretation in clinical trials. Nature review, 2004, 5:229-237.
4. Seifart C, Seifart U, Plagens A, et al. Surfactant protein B gene variations enhance susceptibility to squamous cell carcinoma of the lung in German patients. Br J Cancer,2002, 15, 87: 212-217.
5. Skriagina EM, Abramovskaia AK, Gurevich GL, et al. Differential diagnosis significance of measuring surfactant phospholipid levels in lung diseases. Probl Tuberk, 1998, 4: 51-53.
6. Mao JR, Taylor G, Dean WB, et al. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet,2002, 30:421-425.
7. Lau D, Xue L, Hu R, et al. Expression and regulation of a molecular marker, SPR1, in multistep bronchial carcinogenesis. Am J Respir Cell Mol Biol, 2000, 22: 92-96.
8. Lau D, Guo L, Chan A, et al. SPR1. An early molecular marker for bronchial carcinogenesis. Methods Mol Med, 2003, 75:397-403.
9. Hu R, Wu R, Deng J, et al. A small proline-rich protein, spr1: specific marker for squamous lung carcinoma. Lung Cancer, 20: 25-30.
10. Katoh M, Katoh M. Human FOX gene family expression of RPMS1 in nasopharyngeal. Int J Oncol,2004, 25:1495-500.
11. Kalinichenko VV, Major ML, Wang X, et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev, 2004, 18:830-850.
12. Teh MT, Wong ST, Neill GW, et al. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res,2002, 62:4773-4780.
13. Wonsey DR, Follettie MT. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res, 2005, 65:5181-5189.
14. Laoukili J, Kooistra MR, Bras A, et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol, 2005, 7:126-136.